From: B4GALT5 high expression associated with poor prognosis of hepatocellular carcinoma
Immune Cell | Subunit | Tumor group | Normal group | ||
---|---|---|---|---|---|
 |  | c | p-value | c | p-value |
CD8+ T | CD8A | 0.13 | 0.012 | 0.083 | 0.57 |
 | CD8B | 0.068 | 0.19 | 0.21 | 0.89 |
CD4+ T | CD3D | 0.13 | 0.012 | 0.013 | 0.93 |
 | CD3E | 0.15 | 0.0051 | 0.03 | 0.84 |
 | CD2 | 0.16 | 0.0019 | 0.029 | 0.84 |
B cell | CD19 | 0.066 | 0.21 | -0.005 | 0.97 |
 | CD79A | 0.24 | 0.062 | 0.78 | 0.041 |
Monocyte | CD86 | 0.4 | 1.1E-15 | 0.31 | 0.029 |
 | CD115 | 0.32 | 4.5E-10 | 0.11 | 0.45 |
M1 | NOS2 | 0.009 | 0.86 | -0.076 | 0.6 |
 | IRF5 | 0.47 | 0 | 0.033 | 0.82 |
 | PTGS2 | 0.27 | 2.2E-07 | 0.34 | 0.017 |
M2 | CD163 | 0.15 | 0.0032 | 0.23 | 0.11 |
 | VSIG4 | 0.21 | 6.6E-05 | 0.21 | 0.14 |
 | MS4A4A | 0.18 | 0.00039 | 0.16 | 0.27 |
Neutrophils | CD66b | -0.0048 | 0.93 | -0.061 | 0.67 |
 | CD11b | 0.46 | 0 | 0.17 | 0.24 |
 | CCR7 | 0.095 | 0.067 | 0.16 | 0.27 |
NK | KIR2DL1 | 0.051 | 0.33 | -0.012 | 0.93 |
 | KIR2DL3 | 0.13 | 0.014 | -0.07 | 0.63 |
 | KIR2DL4 | 0.23 | 6.6E-06 | 0.32 | 0.026 |
 | KIR3DL1 | 0.05 | 0.34 | 0.2 | 0.17 |
 | KIR3DL2 | 0.084 | 0.11 | 0.15 | 0.3 |
 | KIR3DL3 | 0.11 | 0.04 | 0.0065 | 0.96 |
 | KIR2DS4 | 0.0091 | 0.86 | 0.12 | 0.41 |
Th1 | TBX21 | 0.12 | 0.022 | 0.093 | 0.52 |
 | STAT4 | 0.31 | 2E-09 | 0.18 | 0.2 |
 | STAT1 | 0.37 | 1.5E-13 | 0.025 | 0.87 |
 | IFNG | 0.13 | 0.015 | 0.16 | 0.25 |
 | TNF | 0.28 | 5.8E-08 | 0.19 | 5.8E-08 |
Th2 | GATA3 | 0.25 | 7E-07 | 0.37 | 0.0073 |
 | STAT6 | 0.33 | 1.3E-10 | 0.29 | 0.044 |
 | STAT5A | 0.36 | 0.044 | 0.23 | 0.044 |
 | IL13 | -0.039 | 0.45 | 0.27 | 0.059 |